Randomised, double blind, placebo controlled study of interferon β-1a in relapsing-remitting multiple sclerosis analysed by area under disability/time curves

OBJECTIVES—The commonly employed outcome measures on disability and relapse rates in treatment trials of relapsing-remitting multiple sclerosis have well demonstrated sensitivity to treatment effects, but their clinical interpretation is problematic. An alternative method of analysis, which is more...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Liu, C., Blumhardt, L.
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Group 1999
Предметы:
Papers
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1736573/
https://ncbi.nlm.nih.gov/pubmed/10486390
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы